CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase.

Hentschke, Moritz; Kotsakis, Stathis D; Wolters, Manuel; Heisig, Peter; Miriagou, Vivi; Aepfelbacher, Martin

Hentschke, Moritz; Kotsakis, Stathis D; Wolters, Manuel; Heisig, Peter; Miriagou, Vivi; Aepfelbacher, Martin.

Affiliation

Hentschke M; Institute of Medical Microbiology, Virology and Hygiene, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. m.hentschke@uke.de

Microb Drug Resist ; 17(2): 165-9, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21388298

Subject(s)

Anti-Bacterial Agents/pharmacology; Cephalosporins/pharmacology; Drug Resistance, Bacterial/genetics; Escherichia coli Infections/microbiology; Escherichia coli Proteins/genetics; Escherichia coli; Plasmids/genetics; Surgical Wound Infection/microbiology; beta-Lactamases/genetics; Drug Resistance, Bacterial/drug effects; Escherichia coli/genetics; Escherichia coli/growth & development; Escherichia coli/isolation & purification; Escherichia coli Infections/drug therapy; Escherichia coli Infections/genetics; Escherichia coli Proteins/metabolism; Humans; Molecular Sequence Data; Plasmids/metabolism; Serine/genetics; Serine/metabolism; Surgical Wound Infection/drug therapy; Surgical Wound Infection/genetics; Valine/genetics; Valine/metabolism; beta-Lactamases/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasmids / Surgical Wound Infection / Beta-Lactamases / Cephalosporins / Escherichia coli Proteins / Drug Resistance, Bacterial / Escherichia coli / Escherichia coli Infections / Anti-Bacterial Agents Limits: Humans Language: En Journal: Microb Drug Resist Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2011 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google